The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
100 jobs Number of planned job losses
Announcement Date
31 March 2016
Employment effect (start)
1 April 2016
Foreseen end date
31 December 2016
Description
Pharmaceutical manufacturer, Ranbaxy, is to close its plant in Cashel, Co Tipperary, with the expected loss of 100 jobs. The plant was acquired by Sun Pharma last year, and talks on the future of the plant got underway shortly after. It was announced on March 31 that the plant is to close by the end of 2016. Ranbaxy employ 100 people at the plant. The company said there is the possibility of laboratory workers moving to other Sun Pharma locations. The Cashel plant was first opened in 1984.
Unite the union, which represents 70 of the workers, said it was disappointed with the decision to close the plant but that it "will be engaging with management to secure the best terms for our members, who have given long and dedicated service to the company."
Sources
31 March 2016: RTE
31 March 2016: The Irish Times
1 April 2016: Irish Examiner
Citation
Eurofound (2016), Ranbaxy, Closure in Ireland, factsheet number 86891, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/86891.